The prevention of cardiovascular disease: Emphasis on Secondary Prevention
References (270)
- et al.
Does physical activity lower blood pressure? A critical review of the clinical trials
J Clin Epidemiol
(1992) - et al.
Profile of coronary arterial disease in diabetic patients undergoing coronary arterial bypass grafting
Int J Cardiol
(1991) - et al.
Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease
Atherosclerosis
(1981) Epidemiology of stroke
Lancet
(1992)- et al.
Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
J Am Coll Cardiol
(1986) - et al.
Perioperative morbidity in diabetics requiring coronary artery bypass surgery
Ann Thorac Surg
(1988) - et al.
Blood pressure, stroke, and coronary heart disease
Part 2, short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context. Lancet
(1990) - et al.
Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: The Framingham Study
Am Heart J
(1993) - et al.
Morbidity and mortality in the Swedish Trial in Old Patients with hypertension (STOP-Hypertension)
Lancet
(1991) - et al.
Treatment of hyperlipidemia retards progression of symptomatic femoral atherosclerosis: A randomized controlled trial
Lancet
(1983)
Fibrinogen genotype and risk of peripheral atherosclerosis
Lancet
(1992)
Alteration of the type A behavior and reduction in cardiac recurrences in postmyocardial infarction patients
Am Heart J
(1984)
Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: Summary results of the recurrent coronary prevention project
Am Heart J
(1986)
Oestrogens and atherosclerotic vascular disease—local factors
Bailliere's Clin Endocrinol Metab
(1993)
Prevalence of risk factors in men with premature coronary artery disease
Am J Cardiol
(1991)
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke
Lancet
(1989)
Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study
Lancet
(1992)
Postmenopausal use of estrogen and occlusion of coronary arteries
Am Heart J
(1988)
Cardiogenic embolism to the brain
Lancet
(1992)
The impact of diabetes on survival following myocardial infarction in men vs women
JAMA
(1988)
Cessation of smoking after myocardial infarction
Effects on mortality after 10 years. Br Heart J
(1983)
Inhibition of coronary artery. Atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone
Arteriosclerosis
(1990)
Guidelines for counseling postmenopausal women about preventive hormone therapy
Ann Intern Med
(1992)
1993 heart and Stroke Facts
(1992)
Secondary prevention of vascular disease by prolonged antiplatelet treatment
BMJ
(1988)
Nonpharmacologic intervention to reduce blood pressure in older patients with mild hypertension
Arch Intern Med
(1992)
The Prospective Cardiovascular Minister Study: Prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension
Am J Cardiol
(1987)
Study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis
Stroke
(1989)
Regression and progression of early femoral. Atherosclerosis intreated hyperlipoproteinemic patients
Ann Intern Med
(1977)
A meta-analysis of physical activity in the prevention of coronary heart disease
Am J Epidemiol
(1990)
Increase in body fatness as a major determinant of changes in serum total cholesterol and high density lipoprotein cholesterol in young men over a 10-year period
Am J Epidemiol
(1989)
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis on coronary venous bypass grafts
JAMA
(1987)
Behavioral approaches to secondary prevention of coronary heart disease
Circulation
(1987)
Cigarette smoking and risk of premature stroke in men and women
BMJ
(1986)
Diabetes, intermittent claudication, and risk of cardiovascular events: The Framingham Study
Diabetes
(1989)
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
N Engl J Med
(1990)
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
N Engl J Med
(1990)
Blood pressure
Trends in CHD mortality, morbidity and risk factor levels from 1960 to 1986: The Minnesota Heart Survey
Int J Epidemiol
(1989)
Smoking following myocardial infarction: A critical review of the literature
Health Psychol
(1984)
Cardiovascular mortality and noncontra-ceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
Circulation
(1987)
Nonrheumatic atrial fibrillation: Risk of stroke and role of antithrombotic therapy
Circulation
(1991)
The evolution of medical and surgical therapy for coronary artery disease: A 15-year perspective
JAMA
(1989)
A randomized trial of aspirin and sulfinpyrazone in threatened stroke
N Engl J Med
(1978)
Hypotensive therapy in stroke survivors
Lancet
(1970)
Carotid surgery versus medical therapy in asymptomatic carotid stenosis
Stroke
(1991)
Type A behavior and survival after acute myocardial infarction
N Engl J Med
(1985)
Beneficial effects of colestipol and niacin on coronary atherosclerosis: A 4-year follow-up
JAMA
(1990)
Cardiogenic brain embolism
Arch Neurol
(1986)
Cited by (26)
Prevention of coronary artery disease
2000, Primary Care - Clinics in Office PracticeCitation Excerpt :Diabetes is a prominent risk factor increasing the mortality from CAD two to fours times higher than nondiabetic patients. As a risk factor, diabetes has a greater impact on women than men.68 Indeed, the lower CAD risk seen in premenopausal women is negated in premenopausal women with diabetes when compared with age-matched men.43
Hypertension, hormones, and aging
2000, Journal of Laboratory and Clinical MedicineSpecialty differences in cardiovascular disease prevention practices
1998, Journal of the American College of CardiologyA depsipeptide fungal metabolite inhibitor of cholesteryl ester transfer protein
1998, Bioorganic and Medicinal Chemistry LettersWiedendiol-A and -B, cholesteryl ester transfer protein inhibitors from the marine sponge Xestospongia wiedenmayeri
1995, Bioorganic and Medicinal Chemistry Letters
Copyright © 1994 Elsevier Inc. All rights reserved.